OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Help
Advanced
Search
17
Results
Show all
Save search
Copy query
Show results for
Unknown
(16)
Metabolomics
(1)
Repository
MetaboLights
(1)
Technology Type
Mass spectrometry
(1)
Instrument Platform
Xevo G2 QTOF (Waters)
(1)
Publication Date
2018
(1)
CHEBI ID
CHEBI:141364
(1)
CHEBI:141362
(1)
CHEBI:138394
(1)
CHEBI:141366
(1)
CHEBI:71172
(1)
CHEBI:34485
(1)
CHEBI:88108
(1)
CHEBI:74340
(1)
CHEBI:81555
(1)
CHEBI:17033
(1)
CHEBI:76078
(1)
CHEBI:86255
(1)
CHEBI:43580
(1)
CHEBI:73858
(1)
CHEBI:16359
(1)
CHEBI:72998
(1)
CHEBI:16990
(1)
Metabolite Name
LysoPC (LPC) (17:0/0:0)
(1)
LysoPC (LPC) (18:1(11Z)/0:0)
(1)
LysoPC (LPC) (18:0/0:0)
(1)
LysoPC (LPC) (16:0/0:0)
(1)
LysoPC (LPC) (0:0/16:0)
(1)
LysoPC (LPC) (18:2(9Z,12Z))
(1)
Cholic Acid (Dimer—no parent) (CA)
(1)
Biliverdin (BLD)
(1)
3-oxocholic acid -H2O (OCA)
(1)
(9Z,12Z)-(8R)-8-Hydroperoxyoctadeca-9,12-dienoic acid (HPODE)
(1)
Bilirubin (BR)
(1)
N-[(3alpha,5beta,12alpha)-3,12-Dihydroxy-7,24-dioxocholan-24-yl]glycine (NDGCA)
(1)
3-indolepropionic acid (3IPA)
(1)
Enterolactone (EL)
(1)
Hexahydrohippurate (HHA)
(1)
N-(cyclohex-1-en-1-ylcarbonyl)glycine (NCG)
(1)
N-Methylhippuric Acid (NMHA)
(1)
Release Date
2025
(4)
2024
(4)
2022
(3)
2020
(2)
2023
(1)
2017
(1)
2014
(1)
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
DIVA Metabolomics: Differentiating Vaccination Status Following Viral Challenge Using Metabolomic Profiles
This study employed metabolomic profiling technologies, to identify metabolites (small molecules) in blood which are found at different levels in vaccinated compared to non-vaccinated animals exposed to virus.
2018-07-13
|
MTBLS456
|
MetaboLights
Cite
Metastasis is regulated via microRNA-200/ZEB1 axis control of tumour cell PD-L1 expression and intratumoral immunosuppression.
Not available
S-EPMC4212319
|
biostudies-literature
Cite
Regulation of mitophagy by the NSL complex underlies genetic risk for Parkinson's disease at 16q11.2 and MAPT H1 loci.
Not available
S-EPMC9762952
|
biostudies-literature
Cite
Evaluating the Appropriate Use Criteria for Coronary Revascularization in Stable Ischemic Heart Disease Using Randomized Data From the ISCHEMIA Trial.
Not available
S-EPMC11919559
|
biostudies-literature
Cite
Health-Status Outcomes with Invasive or Conservative Care in Coronary Disease.
Not available
S-EPMC7261489
|
biostudies-literature
Cite
Arthroplasty-CervicalP001 - Double Crush Syndrome of the Vertebral Artery Loop and Foraminal Stenosis Causing Monoparesis
Not available
S-EPMC5724662
|
biostudies-literature
Cite
Initial Invasive or Conservative Strategy for Stable Coronary Disease.
Not available
S-EPMC7263833
|
biostudies-literature
Cite
Prevalence of physical frailty, including risk factors, up to 1 year after hospitalisation for COVID-19 in the UK: a multicentre, longitudinal cohort study.
Not available
S-EPMC10005893
|
biostudies-literature
Cite
Common, low-frequency, rare, and ultra-rare coding variants contribute to COVID-19 severity.
Not available
S-EPMC8661833
|
biostudies-literature
Cite
Plasma AR Alterations and Timing of Intensified Hormone Treatment for Prostate Cancer: the STAMPEDE Phase 3 Randomized Clinical Trial.
Not available
S-EPMC11869088
|
biostudies-literature
Cite
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets